Hikma Pharmaceutical | HIK - Ebitda

Prix De L'Action
1,377.75
Variation Quotidienne
-7.25 -0.52%
Mensuellement
9.61%
Annuel
-28.87%
Q2 Prévisions
1,361.73




Ebitda Changement Date
Almirall EUR 114.07M 60.37M 2025-12
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Autolus Therapeutics Ltd USD -70.08M 11.23M 2025-09
Bayer EUR 1.97B 457M 2025-12
Fresenius EUR 850M 22M 2025-09
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Orion EUR 130.4M 212.6M 2026-03
Recordati EUR 247.15M 421K 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12